Holding/activity history for BioMarin Pharmaceutical Inc. (BMRN)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2024 Q3 | 9,753,293 | 2.50 | Add 38.08% | 0.69 | $70.29 |
| 2024 Q2 | 7,063,564 | 2.23 | Add 10.09% | 0.20 | $82.33 |
| 2024 Q1 | 6,416,288 | 2.09 | Add 31.23% | 0.50 | $87.34 |
| 2023 Q4 | 4,889,454 | 1.73 | Add 15.99% | 0.24 | $96.42 |
| 2023 Q3 | 4,215,456 | 1.52 | Add 1.41% | 0.02 | $88.48 |
| 2023 Q2 | 4,156,785 | 1.48 | Add 91.68% | 0.71 | $86.68 |
| 2023 Q1 | 2,168,617 | 0.99 | Reduce 58.88% | 1.42 | $97.24 |
| 2022 Q4 | 5,273,620 | 2.74 | Add 3.42% | 0.09 | $103.49 |
| 2022 Q3 | 5,099,164 | 2.00 | Add 0.92% | 0.02 | $84.77 |
| 2022 Q2 | 5,052,593 | 1.92 | Add 34.65% | 0.49 | $82.87 |
| 2022 Q1 | 3,752,393 | 1.17 | Add 30.75% | 0.28 | $77.10 |
| 2021 Q4 | 2,869,947 | 0.74 | Buy | 0.74 | $88.35 |
| 2020 Q2 | 0 | 0 | Sell 100.00% | 0.64 | |
| 2020 Q1 | 1,453,625 | 0.64 | Reduce 10.37% | 0.07 | $84.50 |
| 2019 Q4 | 1,621,739 | 0.64 | Reduce 46.97% | 0.57 | $84.55 |
| 2019 Q3 | 3,058,104 | 1.07 | Add 18.06% | 0.16 | $67.40 |
| 2019 Q2 | 2,590,351 | 1.00 | Reduce 49.50% | 0.98 | $85.65 |
| 2019 Q1 | 5,128,909 | 2.61 | $88.83 |